Navigation Links
JS Genetics announces launch of XCAT-KS, a bloodless, cheek swab test for the diagnosis of Klinefelter syndrome and other Male sex chromosome aneuploidies
Date:5/2/2012

NEW HAVEN, Conn., May 2, 2012 /PRNewswire/ -- JS Genetics announces the availability of XCAT-KS, its proprietary buccal swab test for the diagnosis of Klinefelter syndrome (KS) and other male sex chromosome aneuploidies. Klinefelter syndrome, a condition in which males have an extra X chromosome, is one of the most common genetic abnormalities in males.  It is estimated that about one in every 500 males has an extra X chromosome.

Klinefelter syndrome can affect physical development resulting in low muscle tone, infertility, gynecomastia and hypogonadism.  KS can also result in language development disorders including delayed speech and social problems such as shyness and moody behavior. However, the diagnosis of KS is not readily apparent on physical exams or by routine testing. Only 25% of KS patients are diagnosed during their lifetime. 

XCAT-KS is a PCR / pyrosequencing based test which identifies Klinefelter syndrome and other male sex chromosome aneuploidies with 100% sensitivity and specificity as detailed in a validation study published in the International Journal of Pediatric Endocrinology (2012:8  23 April 2012). 

The results of the XCAT-KS will typically be available within 3 business days following receipt of the buccal swabs at JS Genetics' CLIA certified laboratory.

In other news, JS Genetics announces that it has been awarded re-accreditation by the College of American Pathologists (CAP).  As part of the biannual re-accreditation program, CAP inspectors examine laboratory staff qualifications, as well as the laboratory's equipment, facilities and records, and the overall management of the laboratory.  The CAP Laboratory Accreditation Program, begun in the early 1960s, is recognized by the US Federal government as being equal to or more stringent than the government's own inspection program and is designed to specifically ensure the highest standard of care for all laboratory patients.

About JS Genetics
JS Genetics Inc., a private company, develops and markets proprietary, high value DNA diagnostic tests for medical conditions in newborns, children, and adolescents. (CLIA ID# 07D1091103; CAP# 72115351)

For more information about JS Genetics or XCAT-KS  visit www.jsgenetics.com.  Physicians who would like to obtain testing kits at no charge can order at www.jsgenetics.com or call 1-888-217-8947.


'/>"/>
SOURCE JS Genetics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Khan Academy and 23andMe Partner to Promote Genetics Education on DNA Day
2. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
3. Genetics Policy Institute (GPI) Files Additional Legal Arguments in Sherley v. Sebelius Stem Cell Case
4. GeneThera, Inc. Acquires Applied Genetics, S.A.
5. deCODE Genetics, in Collaboration with Academic Colleagues, Discovers Three Variants in the Sequence of the Human Genome that Affect the Risk of Thyroid Cancer
6. Cytogenetics - Technologies, Markets and Companies
7. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
8. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
9. Interleukin Genetics Reports Third Quarter 2011 Financial Results
10. Interleukin Genetics, Inc. Announces Conference Call to Discuss Third Quarter 2011 Results
11. Myriad Genetics Receives the "Corporate Spirit of Giving Award" From the Utah Philanthropy Day Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017  United ... announced its financial results for the fourth quarter ... annual 2016 financial results reflect continued growth as ... $700 million," said Martine Rothblatt, Ph.D., United Therapeutics, ... strengthen our ability to develop and advance our ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... Biopsy System , a fully automated benchtop system for collecting intact circulating tumor ... being launched at the Molecular Medicine Tri Conference (Tri-Con) Annual Meeting 2017 (February ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... -Sciences division, Treximo will pair its $200M operational capacity with its strategic ... project management in areas affecting quality and operational management. With office ...
(Date:2/21/2017)... Feb. 21, 2017  Lexus, a returning partner of the ... official and exclusive automobile partner of the men,s and women,s events ... The 2017 Amgen Tour of California ... some of the best professional cycling teams in the world racing ... The four-day Amgen Breakaway from Heart Disease TM ...
Breaking Biology Technology:
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
Breaking Biology News(10 mins):